Oncology Trial Imaging. End to End.
Phase I. Phase II. And Beyond.
Built by radiologists who understand what oncologists need. Affordable for early-stage biotechs.
Built by radiologists who understand what oncologists need. Affordable for early-stage biotechs.
The first SaaS DICOM platform built for early-phase oncology. Collect, QA, store, and access your trial imaging data — with full ownership, no lock-in, live from Day 1.
BioSUITE
Volumetric tumor analysis — MTV, viable tumor volume, 3D segmentation — that turns signals into quantitative, defensible go/no-go decisions.
Blinded, standardized image evaluation by oncology subspecialist radiologists. All major criteria. 24–72 hour turnaround. Results directly in your dashboard.
30 minutes is enough to understand if Volumetryx fits your trial.
No commitment, no sales script. Just the platform and your questions.
